Bain Capital has agreed to acquire Mitsubishi Chemical Group’s pharmaceutical business for more than $3 billion, a deal that would allow the Japanese company to focus on its key chemical businesses.

The two parties are set to enter into a 10-year, nonexclusive strategic investment-management relationship.

Bain Capital LP has entered into a definitive agreement with Mitsubishi Chemical Group Corp. on the acquisition of Mitsubishi Nanabe Pharma Corp. (MTPC). This is reported in a press release from Bain ...

Bain Capital has agreed to buy restaurant-chain operator Sizzling Platter from CapitalSpring for more than $1 billion including debt, according to people with knowledge of the matter.